Three-year duration of benefit from abciximab in patient receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study [5] Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Anticoagulants
  • Immunoglobulin Fab Fragments
  • Myocardial Infarction
  • Stents

publication date

  • June 2006

Research

keywords

  • Article

Identity

Digital Object Identifier (DOI)

  • 10.1093/eurheartj/ehl008

Additional Document Info

start page

  • 1508

end page

  • 9; author reply 1509

volume

  • 27

number

  • 12